134 related articles for article (PubMed ID: 14606614)
1. Use of the protease inhibitor saquinavir hard gel in human immunodeficiency virus-infected patients in the early period of highly active antiretroviral therapy: does it affect long-term treatment outcome?
Jensen-Fangel S; Pedersen C; Nielsen H; Tauris P; Møller A; Sørensen HT; Obel N
Scand J Infect Dis; 2003; 35(10):743-9. PubMed ID: 14606614
[TBL] [Abstract][Full Text] [Related]
2. The insufficient suppression of viral load by saquinavir hard gel is reversible: a retrospective cohort study.
Jensen-Fangel S; Kirk O; Blaxhult A; Gerstoft J; Pedersen C; Black FT; Lundgren JD; Obel N
HIV Clin Trials; 2001; 2(2):122-7. PubMed ID: 11590520
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir.
Kirk O; Mocroft A; Pradier C; Bruun JN; Hemmer R; Clotet B; Miller V; Viard JP; Phillips AN; Lundgren JD;
AIDS; 2001 May; 15(8):999-1008. PubMed ID: 11399982
[TBL] [Abstract][Full Text] [Related]
4. Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection.
Figgitt DP; Plosker GL
Drugs; 2000 Aug; 60(2):481-516. PubMed ID: 10983742
[TBL] [Abstract][Full Text] [Related]
5. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients.
d'Arminio Monforte A; Lepri AC; Rezza G; Pezzotti P; Antinori A; Phillips AN; Angarano G; Colangeli V; De Luca A; Ippolito G; Caggese L; Soscia F; Filice G; Gritti F; Narciso P; Tirelli U; Moroni M
AIDS; 2000 Mar; 14(5):499-507. PubMed ID: 10780712
[TBL] [Abstract][Full Text] [Related]
6. Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.
Hammer SM; Vaida F; Bennett KK; Holohan MK; Sheiner L; Eron JJ; Wheat LJ; Mitsuyasu RT; Gulick RM; Valentine FT; Aberg JA; Rogers MD; Karol CN; Saah AJ; Lewis RH; Bessen LJ; Brosgart C; DeGruttola V; Mellors JW;
JAMA; 2002 Jul; 288(2):169-80. PubMed ID: 12095381
[TBL] [Abstract][Full Text] [Related]
7. Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz.
Lucas GM; Chaisson RE; Moore RD
AIDS; 2001 Sep; 15(13):1679-86. PubMed ID: 11546943
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.
Grabar S; Pradier C; Le Corfec E; Lancar R; Allavena C; Bentata M; Berlureau P; Dupont C; Fabbro-Peray P; Poizot-Martin I; Costagliola D
AIDS; 2000 Jan; 14(2):141-9. PubMed ID: 10708284
[TBL] [Abstract][Full Text] [Related]
9. Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort study.
Jensen-Fangel S; Kirk O; Larsen L; Blaxhult A; Gerstoft J; Pedersen C; Black FT; Lundgren JD; Obel N
Scand J Infect Dis; 1999; 31(5):489-93. PubMed ID: 10576129
[TBL] [Abstract][Full Text] [Related]
10. Antiviral potency of HAART regimens and clinical success are not strictly coupled in real life conditions: evidence from the MASTER-1 study.
Carosi G; Castelli F; Suter F; Maggiolo F; Orani AM; Pan A; Andreoni M; Vigevani GM; Maserati R; Mazzotta F; Tinelli C;
HIV Clin Trials; 2001; 2(5):399-407. PubMed ID: 11673814
[TBL] [Abstract][Full Text] [Related]
11. The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study.
Mocroft A; Phillips AN; Miller V; Gatell J; van Lunzen J; Parkin JM; Weber R; Roge B; Lazzarin A; Lundgren JD;
AIDS; 2001 Jan; 15(2):201-9. PubMed ID: 11216928
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of nelfinavir, ritonavir, or delavirdine in combination with saquinavir-SGC and stavudine in treatment-experienced HIV-1-infected patients.
Smith D; Hales G; Roth N; Law M; Ray J; Druett J; Mitchell J; Mills G; Doong N; Franklin R;
HIV Clin Trials; 2001; 2(2):97-107. PubMed ID: 11590517
[TBL] [Abstract][Full Text] [Related]
13. Randomized salvage therapy with saquinavir-ritonavir versus saquinavir-nelfinavir for highly protease inhibitor-experienced HIV-infected patients.
Chavanet P; Piroth L; Grappin M; Buisson M; Gourdon F; Cabié A; Duong M; Brunel-Dalmas F; Peytavin G; Portier H
HIV Clin Trials; 2001; 2(5):408-12. PubMed ID: 11673815
[TBL] [Abstract][Full Text] [Related]
14. Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients.
Casado JL; Perez-Elías MJ; Antela A; Sabido R; Martí-Belda P; Dronda F; Blazquez J; Quereda C
AIDS; 1998 Jul; 12(11):F131-5. PubMed ID: 9708403
[TBL] [Abstract][Full Text] [Related]
15. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
[TBL] [Abstract][Full Text] [Related]
16. The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
Cardiello P; Srasuebkul P; Hassink E; Mahanontharit A; Samor T; Ruxrungtham K; Lange J; Cooper D; Phanuphak P
HIV Med; 2005 Mar; 6(2):122-8. PubMed ID: 15807718
[TBL] [Abstract][Full Text] [Related]
17. Virologic and immunologic response to a boosted double-protease inhibitor-based therapy in highly pretreated HIV-1-infected patients.
Smith GH; Boulassel MR; Klien M; Gilmore N; MacLeod J; LeBlanc R; René P; Routy JP; Lalonde RG
HIV Clin Trials; 2005; 6(2):63-72. PubMed ID: 15983890
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy.
Piketty C; Race E; Castiel P; Belec L; Peytavin G; Si-Mohamed A; Gonzalez-Canali G; Weiss L; Clavel F; Kazatchkine MD
AIDS; 1999 Jul; 13(11):F71-7. PubMed ID: 10449277
[TBL] [Abstract][Full Text] [Related]
19. Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients. NV15355 Study Team.
Mitsuyasu RT; Skolnik PR; Cohen SR; Conway B; Gill MJ; Jensen PC; Pulvirenti JJ; Slater LN; Schooley RT; Thompson MA; Torres RA; Tsoukas CM
AIDS; 1998 Jul; 12(11):F103-9. PubMed ID: 9708399
[TBL] [Abstract][Full Text] [Related]
20. Virological response to protease inhibitor therapy in an HIV clinic cohort.
Staszewski S; Miller V; Sabin C; Carlebach A; Berger AM; Weidmann E; Helm EB; Hill A; Phillips A
AIDS; 1999 Feb; 13(3):367-73. PubMed ID: 10199227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
